Two more firms following HCA Holdings have lifted their price targets for the hospital giant's shares following its fourth-quarter earnings report. HCA (Ticker: HCA) closed Wednesday's session at $37.18, but WallachBeth's researchers, who rate the company a 'hold,' now see the stock going to $36, up from their previous target of $31. Barclays Capital, meanwhile, has reiterated its 'overweight' rating and raised its target to $44 from $41.

SEE ALSO: More recent analyst actions regarding HCA and other local companies